ALFA Filings
Every announcement, straight from the exchange
Every Bacil Pharma fund raise announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Bacil Pharma approved a Rights Issue of up to ₹50 Crore to raise funds. The Board also noted the resignation of two Independent Directors.
Bacil Pharma's board approved a Rs. 50 Crore fundraise via Rights Issue. The board also increased authorized share capital and accepted resignations of two independent directors.
Bacil Pharma approved raising up to ₹5.0 Crore via Rights or Preferential issues. Management will evaluate options to finalize the fund-raising terms.